Roselabs Bioscience inks loan-licence pact with Bharat Biotech for PFS

18 Jul 2013 Evaluate

Roselabs Bioscience, a group company of Roselabs, has inked loan-licence pact with Hyderabad-based vaccine maker Bharat Biotech for pre-filled syringes (PFS). As part of the pact, Bharat Biotech would use the pre-filled syringe manufacturing facility of Roselabs to manufacture pre-filled syringes for its vaccines.

Roselabs Bioscience and Roselabs Polymers have invested over Rs 400 crore to set up 'pre-filled syringes' (PFS) making facility near Ahmedabad with a capacity to manufacture 8 lakh syringes per day. The company’s facility near Ahmedabad has capabilities to make both glass and polymer (Cyclic Olefin Copolymer) syringes.

Roselab Biosciences, which manufactures glass pre-filled syringes, pre-fillable syringes, formulations and cytotoxic Active Pharmaceutical Ingredients (API) and Roselab Polymers, which delivers sterile, clean and ready to fill pre-fillable polymer syringes, are the group companies of Roselabs.

Peers
Company Name CMP
Redington 270.00
Adani Enterprises 2171.45
Amrapali Industries 14.51
Rashi Peripheral 366.05
PDS 351.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×